Anti-oxidant effect of Caffeine-Q10 supplementatio

Not Applicable

• Conditions: Exercise-induced physiological stress.; Drug or medicament, unspecified; Y93? Z71.3

• Registration Number: IRCT201206204663N10
• Lead Sponsor: niversity of Tabriz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 32

Inclusion Criteria

Inclusion: Female; 20-28 year; healthy; Aerobics athletes; BMI <25; without any anti-inflammatory or medical drug such as caffeine >100 mg/day (during 6 months prior to the study) Exclusion: Diseases; Injuries; Uncontrolled intake of anti-inflammatory drugs during the period; Uncontrolled intake of stimulants during the period;

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malondialdehyde. Timepoint: 30 minutes before first Aerobics session; 30 minutes before last Aerobics session; and 18- 24 hours after supplementation and training protocol. Method of measurement: spectrophotometry.;Anti-oxidant capacity. Timepoint: 30 minutes before first Aerobics session; 30 minutes before last Aerobics session; and 18- 24 hours after supplementation and training protocol. Method of measurement: ferric reducing ability of plasma (frap).

Secondary Outcome Measures

Name	Time	Method
Body Temperature. Timepoint: 30 minutes before every training session. Method of measurement: Thermometer.;Blood Presure. Timepoint: 30 minutes before every trainig session. Method of measurement: Aneroid blood pressure measurement.